UK regulators say people with a ‘significant medical history’ of allergic reactions should not receive the new Pfizer / BioNTech vaccine while investigating two side effects that occurred on the first day of the country’s mass vaccination program
Professor Stephen Powis, National Medical Director for the National Health Service in England, said health authorities are acting on the recommendation of the Agency for Medicines and Health Products, the country’s drug regulator.
“Like the new vaccines, the MHRA advised as a precaution that people with a significant allergic reaction should not receive this vaccine after two people with a significant allergic reaction reacted adversely yesterday,” Powis said. statement. – They’re both recovering well.
THIS IS A HIGHLIGHTING NEWS UPDATE. The previous history of the AP is as follows.
LONDON (AP) – UK regulators have reported two possible allergic reactions that took part in the first day of the British mass coronavirus vaccination program against COVID-19.
Dr June Raine, head of the UK Health Regulatory Agency, reported on these reactions when he testified before a parliamentary committee on Wednesday. The UK on Tuesday began vaccinating the elderly and healthcare workers with a vaccine developed by American pharmaceutical manufacturer Pfizer and German BioNTech, the world’s first to introduce the vaccine.
“We are investigating two case reports of allergic reactions,” he said. “We know from very extensive clinical trials that this was not typical.”
“But if we need to strengthen our advice, now that we’ve gained that experience with the vulnerable population, the groups that have been selected as a priority, we’ll get that advice in the field right away,” he said.
Raine’s comments came as part of a general discussion about how his agency continues to monitor people who have been vaccinated with Pfizer, which was approved for emergency use last week.